csrreporters 
CSR Imperative in Nigeria’s Fight Against Mother-to-Child HIV Transmission
Each day in 2024, 712 children across the world acquired HIV, and nearly 250 died from AIDS-related complications. Among them were Nigerian children, babies born into a preventable tragedy, their lives marked from the first breath by a virus that public health systems and political will could have stopped.
Despite being Africa’s most populous nation and the country with the fourth highest HIV burden globally, Nigeria continues to grapple with an issue the world has significantly moved on from: Mother-to-child transmission (MTCT) of HIV.
In a world where the global average for new childhood HIV infections has dropped by 62 per cent since 2010, Nigeria remains an outlier. The country’s final MTCT rate stubbornly sits at 25 per cent, 15 per cent at six weeks of life and another 10 per cent during breastfeeding. This dismal figure not only undermines WHO’s global elimination benchmark of below 5 per cent but means that around 22,000 Nigerian infants are born HIV-positive each year. That’s one out of every seven such cases globally. And with them comes a cascading crisis of poverty, abandonment, illiteracy, and social exclusion, as AIDS-orphaned children often fall through the cracks of an already stretched social system.
But this is not merely a public health issue, it is also a stark indictment of Nigeria’s corporate social responsibility landscape. For a country with a booming private sector and billion-naira conglomerates, it is troubling how few companies have directed CSR resources toward health-system strengthening, especially in HIV prevention. Corporate sustainability must no longer be defined solely by tree-planting, branded school bags, or social media campaigns. True CSR should be measured by how well the private sector invests in solving pressing, systemic, and often invisible social burdens like MTCT.
Nigeria once had the blueprint. The Global Plan in 2011. The Option B+ strategy in 2016. The reactivation of PMTCT programs in 2018. Even a symbolic gesture, appointing former First Lady Aisha Buhari as the Special Ambassador for Eliminating MTCT. Yet, over a decade later, these ambitions have failed to take root. While South Africa and Uganda boast 70 per cent declines in childhood infections, Nigeria has only managed a paltry 15 per cent. The difference is not in population size or resource availability but in strategy execution, accountability, and shared responsibility.
Health infrastructure in Nigeria remains underfunded and fragile, stretched thin by a wave of medical brain drain and the elite’s preference for medical tourism. An average of $3.6 billion left Nigeria each year during President Muhammadu Buhari’s tenure as citizens sought treatment abroad. This figure alone dwarfs the annual HIV and maternal health budget many times over, and it underlines the systemic inequality and governance failure at play.
Private businesses must now see themselves as stakeholders in Nigeria’s health outcomes. MTCT should not be left to overstretched government programs or underfunded NGOs alone. Companies can and should fund antenatal outreach services, support PMTCT technology infrastructure, and integrate mentor-mother models into their community-based CSR portfolios. At the very least, CSR budgets, especially for firms in extractives, telecoms, and banking, should include maternal and child HIV interventions within their community impact plans.
Faith-based and community organisations, already present in Nigeria’s deepest corners, must also be empowered with funding and training to reduce stigma and ensure adherence. Crucially, there must be a national CSR registry where companies transparently report not just how much they spent, but on what outcomes were achieved. For CSR to be sustainable, it must be impact-led, not optics-driven.
This is not just a matter of corporate ethics. It is a test of whether Nigeria’s private sector truly understands the ‘social’ in ESG. Eliminating MTCT in Nigeria will not only save thousands of infant lives annually, it will restore dignity to motherhood, strengthen communities, and push Nigeria closer to the global 95-95-95 HIV elimination targets.
A society is only as strong as its weakest systems, and in Nigeria, the weakest are being born into HIV with no say in their fate.
If CSR is to mean anything in 2025 and beyond, it must move beyond performative charity and tackle issues like this, with urgency, empathy, and enduring commitment. Because no child should be born with a virus that could have been stopped and no company that claims to care should be absent from that fight.